Sarah Kim

Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems

Computational approaches streamlining drug discovery

Advancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports

Machine Learning in Drug Discovery and Development Part 1: A Primer